SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-22-000033
Filing Date
2022-05-16
Accepted
2022-05-16 16:20:12
Documents
81
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xcur-20220331.htm   iXBRL 10-Q 1488361
2 EX-31.1 exicureexhibit311-33122.htm EX-31.1 8019
3 EX-31.2 exicureexhibit312-33122.htm EX-31.2 7963
4 EX-32.1 exicureexhibit321-33122.htm EX-32.1 8299
10 xcur-20220331_g1.jpg GRAPHIC 29733
  Complete submission text file 0001698530-22-000033.txt   6423577

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20220331.xsd EX-101.SCH 45903
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20220331_cal.xml EX-101.CAL 63015
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20220331_def.xml EX-101.DEF 183229
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20220331_lab.xml EX-101.LAB 578250
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20220331_pre.xml EX-101.PRE 367382
75 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20220331_htm.xml XML 855734
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 22929426
SIC: 2834 Pharmaceutical Preparations